[Impact on quality of life and autonomy of patients aged over 75 years treated with anti-PD-1 for metastatic melanoma: A single-centre prospective study].

This study shows that neither quality of life nor autonomy appears to be affected by anti-PD-1 treatment in patients aged over 75 years. However, these results should be interpreted with caution due to the small number of patients included, the short follow-up period and the single-centre data. Nevertheless, the prospective analysis and the complete onco-geriatric evaluation and monitoring yielded unique and original data. PMID: 33004209 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33004209?dopt=Abstract

Source: Annales de Dermatologie et de Cenereologie - September 27, 2020 Category: Dermatology Authors: Barailler H, Dousset L, Mertens C, Maurel A, Gérard E, Prey S, Dutriaux C, Beylot-Barry M, Pham-Ledard A Tags: Ann Dermatol Venereol Source Type: research